| Beverly Joan Lemaster, | |
|
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
| (907) 729-3300 | |
| Not Available |
| Full Name | Beverly Joan Lemaster |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902826597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 23 (Alaska) | Primary |
| Provider Name | Yukon-kuskokwim Health Corporation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).
› Verified 5 days ago
| Provider Name | Maniilaq Association |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861698805 PECOS PAC ID: 6103881792 Enrollment ID: O20041123000372 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).
› Verified 5 days ago
| Provider Name | Tanana Chiefs Conference |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821201278 PECOS PAC ID: 9537050109 Enrollment ID: O20050111000954 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Beverly Joan Lemaster, 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-3300 | Beverly Joan Lemaster, 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-3300 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.
Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).
› Verified 5 days ago
Dr. Tiffany Nicole Mcdonald, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Muldoon Rd, Anchorage, AK 99504 Phone: 470-090-7257 | |
Ms. Joyce Forrester Sexton, M.A. CCC-A Audiologist Medicare: May Accept Medicare Assignments Practice Location: 4200 Lake Otis Pkwy, Suite 302, Anchorage, AK 99508 Phone: 907-561-1326 Fax: 907-561-2865 | |
Dr. Michelle Fornelli, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2925 Debarr Rd, Anchorage, AK 99508 Phone: 907-257-4916 Fax: 907-257-4885 | |
Angeli Mohanani-posey, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5530 E Northern Lights Blvd, Anchorage, AK 99504 Phone: 907-742-4526 Fax: 907-742-4777 | |
Jamie H Burford, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 3841 Piper St., Suite T-230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Dr. Kindra Robbins, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 3841 Piper St Ste T230, Anchorage, AK 99508 Phone: 907-279-8800 | |
Dr. Emily E Mcmahan, AU.D. Audiologist Medicare: May Accept Medicare Assignments Practice Location: 1005 E Dimond Blvd, Suite 3, Anchorage, AK 99515 Phone: 503-522-4357 |